Insulin lispro (LYS B28, Pro B29)treatment in adolescents with type 1 diabetes;Tratamiento con insulina lispro (Lys B28, Pro B29) en adolescentes y jóvenes con diabetes mellitus tipo 1

Anales Espanoles de Pediatria

Volumn 52, Issue 4, 2000, Pages 334-338

  Tuset Castellano, M J ^a   Martinez Badas I ^a   Alonso Blanco, M ^a   Barrio Castellanos, R ^a  

^a NONE   (Spain)

Author keywords

Childhood; Lispro insulin; Teenagers; Type 1 diabetes

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HUMAN INSULIN; INSULIN LISPRO;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DRUG RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; METABOLIC REGULATION; PATIENT EDUCATION; PATIENT SATISFACTION; PUBERTY; SELF MONITORING; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE;

EID: 0034448918     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Insulin analogues
2. (Lys (B28), Pro (B29))-Human insulin. A rapidly absorbed analogue of human insulin
3. Comparative study of insulin Lispro and regular insulin in prepuberal children with type 1 diabetes
4. Use of insulin lispro in pediatric patients with IDDM
5. Pre-meal insulin analogue insulin Lispro vs Humulin CAR Insulin treatment in young subjects with type 1 diabetes
6. The human insulin analogue insulin Lispro
7. Effects of the short-acting insulin analog (Lys (B28), Pro(B29)) on postpandrial blood glucose control in IDDM
8. Effectiveness of postprandial humalog in toddlers with diabetes
9. Postprandial glycaemia after regular and lispro insulin in children and adolescents with diabetes
10. Long-term efficacy of humalog in subjects with type 1 diabetes mellitus
11. Reduction of post-prandial hyperglucemia and frecuency of hypoglucemia in IDDM patients on insulin-analog treatment
12. Lispro insulin as premeal therapy in type 1 diabetes: Comparison with Humulin R
13. Metabolic efficacy of preprandial administration of Lys (B28), Pro (B29) human insulin analog in IDDM patients. A comparision with human regular insulin during a three-meal test period
14. Prolonged efficacy of short acting insulin lispro in combination with human ultralente in insulin dependent diabetes mellitus
15. Optimization of evening insulin dose in patients using the short acting insulin analog lispro
16. Optimal provision of daytime NPH insulin in patients using the insulin analog lispro
17. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus
18. Comparative study of insulin Lispro and regular insulin in 481 adolescents with type 1 diabetes
19. Insulin Lispro (LP) results in less nocturnal hypoglucemia compared with human insulin in adolescents with type 1 diabetes
20. Lispro or regular insuline for multiple injection therapy in adolescence
21. Health -related quality -of -life results from multinational clinical trials of insulin Lispro